These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


405 related items for PubMed ID: 6126115

  • 21. Update on calcium-channel blocking agents.
    Talbert RL, Bussey HI.
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [Abstract] [Full Text] [Related]

  • 22. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH, Charlap S, Kimmel B, Goldberger J, Phillippides G, Klein N.
    Am J Cardiol; 1986 Feb 26; 57(7):22D-29D. PubMed ID: 3513513
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of angina pectoris with special reference to beta-blockers].
    Weser C.
    Z Arztl Fortbild (Jena); 1982 Mar 15; 76(6):239-43. PubMed ID: 6126050
    [No Abstract] [Full Text] [Related]

  • 24. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH.
    Pharmacol Ther; 1984 Mar 15; 25(3):271-95. PubMed ID: 6151199
    [Abstract] [Full Text] [Related]

  • 25. Rational approach to the medical therapy of angina pectoris: the role of calcium antagonists.
    Maseri A, Parodi O, Fox KM.
    Prog Cardiovasc Dis; 1983 Mar 15; 25(4):269-78. PubMed ID: 6336848
    [No Abstract] [Full Text] [Related]

  • 26. Calcium antagonists for chronic stable angina pectoris.
    Krikler DM.
    Am J Cardiol; 1987 Jan 30; 59(3):95B-100B. PubMed ID: 2880496
    [Abstract] [Full Text] [Related]

  • 27. Managing angina with calcium channel blockers.
    Segal BL, Kotler MN, Iskandrian AS.
    Geriatrics; 1982 Nov 30; 37(11):65-70. PubMed ID: 6127283
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA, Daniëls MC, Holwerda NJ, Withagen PJ, Schelling A, Cleophas TJ, Hendriks MG.
    Br J Clin Pharmacol; 1999 May 30; 47(5):493-8. PubMed ID: 10336572
    [Abstract] [Full Text] [Related]

  • 31. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH.
    Q J Med; 1984 May 30; 53(209):1-16. PubMed ID: 6324268
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative study of the effect of the calcium antagonist nifedipine, the beta receptor blockers acebutolol and propranolol and their combination on electrophysiologic parameters in the human].
    Vey G, Wiese KH, Schramm A, Walter J.
    Z Kardiol; 1984 Feb 30; 73(2):101-5. PubMed ID: 6719982
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of combination nifedipine-propranolol and diltiazem-propranolol with high dose diltiazem monotherapy for stable angina pectoris.
    Morse JR.
    Am J Cardiol; 1988 Nov 15; 62(16):1028-32. PubMed ID: 3055924
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.